November 01, 2018 Corporate and Business News

• AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

• Global M&A Activity Pacing for Another Banner Year, Anchored by North American Dealmaking

• La salud de los bebés en EE. UU. continúa empeorando, indica el Boletín de Calificaciones sobre Nacimientos Prematuros de March Of Dimes

• Back to Home

• Archive History